Literature DB >> 32229341

Physiological stress markers, mental health and objective physical function.

Bianca A Lever-van Milligen1, Femke Lamers2, Johannes H Smit2, Brenda W J H Penninx2.   

Abstract

OBJECTIVE: The observed poorer physical function in persons with mental disorders could partly be due to dysregulation in physiological stress systems. However, an integrated picture of the role of physiological stress systems on objective physical function is lacking. This study examined the association of multiple physiological stress systems with objective physical function, and explored whether these stress systems contribute to the relationship between depression/anxiety and poorer physical function.
METHODS: Data of 2860 persons of the Netherlands Study of Depression and Anxiety was used. Physical function was indicated by hand grip strength assessed using a hand-held dynamometer and lung function assessed using a peak flow meter. Inflammatory markers (CRP, IL-6, TNF-α), salivary cortisol (cortisol awakening response (AUCg, AUCi), evening cortisol) and ANS markers (heartrate, PEP, RSA) were determined. Depression/anxiety disorders were determined using psychiatric interviews. Linear regression analyses were adjusted for sociodemographics, health and lifestyle factors.
RESULTS: Higher inflammation levels were associated with lower hand grip strength (BCRP = -0.21(SE = 0.06), p < .001) and lower lung function (BCRP = -2.07(SE = 0.66), p = .002), BTNF-α = -3.35(SE = 1.42), p = .022). Higher salivary cortisol levels were associated with lower lung function (Bevening cortisol = -2.22(SE = 0.59), p < .001). The association, in women, between depression/anxiety disorders and poorer physical function did not significantly diminish after adjustment for physiological stress markers.
CONCLUSION: This large cohort study showed that stress system dysfunction (especially the immune-inflammatory system and HPA-axis) contributes to poorer objective physical function. Stress system dysfunction did not explain the poorer physical function observed in persons with depression/anxiety disorders, suggesting that other pathways are involved to explain that association.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Hand grip strength; Lung function; Physical function; Physiological stress

Year:  2020        PMID: 32229341     DOI: 10.1016/j.jpsychores.2020.109996

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  The 5-year pre- and post-hospitalization treated prevalence of mental disorders and psychotropic medication use in critically ill patients: a Canadian population-based study.

Authors:  Kendiss Olafson; Ruth Ann Marrie; James M Bolton; Charles N Bernstein; O Joseph Bienvenu; Maia S Kredentser; Sarvesh Logsetty; Dan Chateau; Yao Nie; Marcus Blouw; Tracie O Afifi; Murray B Stein; William D Leslie; Laurence Y Katz; Natalie Mota; Renée El-Gabalawy; Murray W Enns; Christine Leong; Sophia Sweatman; Jitender Sareen
Journal:  Intensive Care Med       Date:  2021-09-08       Impact factor: 17.440

2.  The relation of common inflammatory cytokines with anxiety and depression and their values in estimating cardiovascular outcomes in coronary heart disease patients.

Authors:  Hanmei Lu; Qinling Yang; Yan Zhang
Journal:  J Clin Lab Anal       Date:  2022-05-02       Impact factor: 3.124

3.  The Effect of Environmental Stressors on Patient Experience in Medical, Surgical, and COVID-19 Intensive Care Unit.

Authors:  Semra Bulbuloglu; Fadime Çınar; Gülsüm Nihal Çürük
Journal:  J Patient Exp       Date:  2022-04-12

4.  Fear in the Chinese Population: Influential Patterns in the Early Stage of the COVID-19 Pandemic.

Authors:  Beijing Chen; Xiaoxiao Sun; Fei Xie; Mengjia Zhang; Sitong Shen; Zhaohua Chen; Yuan Yuan; Peixia Shi; Xuemei Qin; Yingzhe Liu; Yuan Wang; Qin Dai
Journal:  Front Psychol       Date:  2021-06-01

5.  New challenges in the COVID-19 pandemic.

Authors:  Jess G Fiedorowicz
Journal:  J Psychosom Res       Date:  2020-04-22       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.